以上内容来自Benzinga Earnings专栏,原文如下:
Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(1.27) per share which beat the analyst consensus estimate of $(1.36) by 6.62 percent. This is a 13.01 percent increase over losses of $(1.46) per share from the same period last year. The company reported quarterly sales of $12.87 million which beat the analyst consensus estimate of $8.53 million by 50.89 percent. This is a 771.57 percent increase over sales of $(1.92 million) the same period last year.
精彩评论